We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SRE:BMVSempra Analysis

Data as of 2026-08-08 - not real-time

$83.88

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Sempra is bearish at $83.88, with short-term averages lagging the long-term ones. Across the trailing 30 sessions it lost 10.2%. Momentum indicators put RSI at 25.9 (oversold) with MACD reading bearish. Price has been bracketed by support at $83.65 and resistance at $95.61.
The shares look fair, trading on 24.3 times earnings above a sector average of 19.9. Consensus targets land 24.9% above where the shares trade now. The 3.14% dividend yield looks stretched against payout coverage.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 18.7%, a beta of 0.17 and a maximum drawdown of 15.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 2 out of 10.

Top Market Events

San Diego Gas & Electric, Sempra’s utility subsidiary, reports that more than one in four customers now generate...KITV19dSempra to Report Second-Quarter 2026 Earnings on August 6SAN DIEGO, July 20, 2026 /PRNewswire/ -- Sempra NYSE:...Yahoo Finance18dSempra's Quarterly Earnings Preview: What You Need to KnowThe above button links to Coinbase.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 25.9 signals oversold conditions
  • Trading below the 200-day average of 91.77

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 25.9 signals oversold conditions
  • P/E of 24.3 versus sector average of 19.9

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 24.3 versus sector average of 19.9
  • Dividend yield of 3.14% looks stretched against payout coverage
  • Analyst targets imply +24.9% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-0.10%
Profit Margin16.82%
P/E Ratio24.3
ROE6.68%
ROA1.96%
Debt/Equity84.66
P/B Ratio1.7
Op. Cash Flow$5.4B
Free Cash Flow$-27657750528
Industry P/E19.9

Technical Analysis

TrendBearish
RSI25.9
Support$83.65
Resistance$95.61
MA 20$90.14
MA 50$91.13
MA 200$91.77
MACDBearish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair Value$18.21
Target Price$104.81
Upside/Downside24.95%
GradeFair
TypeValue
Dividend Yield3.14%

Risk Assessment

Beta0.17
Volatility18.67%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.